Central Trust CO Uni Qure N.V. Transaction History

Central Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$29.97 - $37.17 $2,097 - $2,601	-70 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$29.24 - $42.03 $292 - $420	-10 Reduced 12.5%	70 $2,000
Q4 2020 Jan 29, 2021	BUY	$35.35 - $50.67 $353 - $506	10 Added 14.29%	80 $2,000
Q3 2020 Oct 22, 2020	BUY	$35.98 - $47.66 $2,518 - $3,336	70 New	70 $2,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.